Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

NASDAQ:BLBD - Nasdaq - US0953061068 - Common Stock - Currency: USD

40.82  -0.43 (-1.04%)

After market: 40.82 0 (0%)

Fundamental Rating

5

Overall BLBD gets a fundamental rating of 5 out of 10. We evaluated BLBD against 128 industry peers in the Machinery industry. BLBD has only an average score on both its financial health and profitability. BLBD may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make BLBD suitable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BLBD was profitable.
BLBD had a positive operating cash flow in the past year.
In multiple years BLBD reported negative net income over the last 5 years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

BLBD has a better Return On Assets (19.89%) than 98.44% of its industry peers.
BLBD has a Return On Equity of 56.80%. This is amongst the best in the industry. BLBD outperforms 98.44% of its industry peers.
Looking at the Return On Invested Capital, with a value of 28.98%, BLBD belongs to the top of the industry, outperforming 98.44% of the companies in the same industry.
Industry RankSector Rank
ROA 19.89%
ROE 56.8%
ROIC 28.98%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLBD has a better Profit Margin (7.97%) than 61.72% of its industry peers.
In the last couple of years the Profit Margin of BLBD has grown nicely.
The Operating Margin of BLBD (9.74%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BLBD has grown nicely.
BLBD has a worse Gross Margin (19.18%) than 74.22% of its industry peers.
BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.74%
PM (TTM) 7.97%
GM 19.18%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

5

2. Health

2.1 Basic Checks

BLBD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
BLBD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BLBD has been increased compared to 5 years ago.
Compared to 1 year ago, BLBD has an improved debt to assets ratio.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 5.81 indicates that BLBD is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 5.81, BLBD is doing good in the industry, outperforming 78.91% of the companies in the same industry.
BLBD has a debt to FCF ratio of 1.07. This is a very positive value and a sign of high solvency as it would only need 1.07 years to pay back of all of its debts.
BLBD has a Debt to FCF ratio of 1.07. This is amongst the best in the industry. BLBD outperforms 86.72% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that BLBD is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.46, BLBD is in line with its industry, outperforming 50.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1.07
Altman-Z 5.81
ROIC/WACC2.76
WACC10.49%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

A Current Ratio of 1.45 indicates that BLBD should not have too much problems paying its short term obligations.
BLBD has a Current ratio of 1.45. This is in the lower half of the industry: BLBD underperforms 76.56% of its industry peers.
BLBD has a Quick Ratio of 1.45. This is a bad value and indicates that BLBD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.73, BLBD is doing worse than 82.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.73
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.76% over the past year.
BLBD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.38% yearly.
BLBD shows a small growth in Revenue. In the last year, the Revenue has grown by 7.57%.
The Revenue has been growing slightly by 5.74% on average over the past years.
EPS 1Y (TTM)22.76%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%7.87%
Revenue 1Y (TTM)7.57%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%3.74%

3.2 Future

The Earnings Per Share is expected to grow by 6.83% on average over the next years.
Based on estimates for the next years, BLBD will show a small growth in Revenue. The Revenue will grow by 5.57% on average per year.
EPS Next Y11.4%
EPS Next 2Y10.42%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue Next Year8.94%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.47, the valuation of BLBD can be described as very reasonable.
Based on the Price/Earnings ratio, BLBD is valued cheaply inside the industry as 91.41% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BLBD to the average of the S&P500 Index (26.60), we can say BLBD is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.62, the valuation of BLBD can be described as very reasonable.
89.84% of the companies in the same industry are more expensive than BLBD, based on the Price/Forward Earnings ratio.
BLBD is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.43, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.47
Fwd PE 9.62
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BLBD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BLBD is cheaper than 82.03% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BLBD is valued a bit cheaper than 79.69% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.02
EV/EBITDA 8.64
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BLBD may justify a higher PE ratio.
PEG (NY)1.01
PEG (5Y)0.7
EPS Next 2Y10.42%
EPS Next 3Y6.83%

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (5/20/2025, 6:11:11 PM)

After market: 40.82 0 (0%)

40.82

-0.43 (-1.04%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners112.01%
Inst Owner Change6.18%
Ins Owners0.09%
Ins Owner Change8.66%
Market Cap1.31B
Analysts83.08
Price Target54.06 (32.44%)
Short Float %16.41%
Short Ratio10.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.87%
Min EPS beat(2)-0.8%
Max EPS beat(2)10.53%
EPS beat(4)3
Avg EPS beat(4)24.77%
Min EPS beat(4)-0.8%
Max EPS beat(4)74.11%
EPS beat(8)7
Avg EPS beat(8)53.29%
EPS beat(12)9
Avg EPS beat(12)-95.09%
EPS beat(16)10
Avg EPS beat(16)-86.39%
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)-0.19%
Revenue beat(4)1
Avg Revenue beat(4)0.55%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)4.08%
Revenue beat(12)8
Avg Revenue beat(12)5.72%
Revenue beat(16)10
Avg Revenue beat(16)4.68%
PT rev (1m)0%
PT rev (3m)-6.09%
EPS NQ rev (1m)-4.69%
EPS NQ rev (3m)-4.69%
EPS NY rev (1m)-4.07%
EPS NY rev (3m)-4.07%
Revenue NQ rev (1m)1.65%
Revenue NQ rev (3m)1.65%
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)-1.14%
Valuation
Industry RankSector Rank
PE 11.47
Fwd PE 9.62
P/S 0.97
P/FCF 15.02
P/OCF 11.86
P/B 6.88
P/tB 10.16
EV/EBITDA 8.64
EPS(TTM)3.56
EY8.72%
EPS(NY)4.24
Fwd EY10.39%
FCF(TTM)2.72
FCFY6.66%
OCF(TTM)3.44
OCFY8.43%
SpS42.24
BVpS5.93
TBVpS4.02
PEG (NY)1.01
PEG (5Y)0.7
Profitability
Industry RankSector Rank
ROA 19.89%
ROE 56.8%
ROCE 41.65%
ROIC 28.98%
ROICexc 49.31%
ROICexgc 73.58%
OM 9.74%
PM (TTM) 7.97%
GM 19.18%
FCFM 6.44%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score8
Asset Turnover2.49
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1.07
Debt/EBITDA 0.59
Cap/Depr 152.12%
Cap/Sales 1.71%
Interest Coverage 12.82
Cash Conversion 75.01%
Profit Quality 80.71%
Current Ratio 1.45
Quick Ratio 0.73
Altman-Z 5.81
F-Score8
WACC10.49%
ROIC/WACC2.76
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.76%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%7.87%
EPS Next Y11.4%
EPS Next 2Y10.42%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue 1Y (TTM)7.57%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%3.74%
Revenue Next Year8.94%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5YN/A
EBIT growth 1Y7.72%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year38.79%
EBIT Next 3Y15.18%
EBIT Next 5YN/A
FCF growth 1Y249.42%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y248.76%
OCF growth 3YN/A
OCF growth 5Y14.81%